缺血性卒中采用静脉内肝素疗法的决定因素  

Determinants of IV heparin treatment in patients with ischemic stroke

作　　者：Schmidt W.-P. Heuschmann P. Taeger D. K. Berger 张玉龙 

机构地区：[1]Inst. of Epide miol. and Social Med., University of Muenster, Domagkstrasse 3, 48149 Muenster, Germany Dr.

出　　处：《世界核心医学期刊文摘（神经病学分册）》2005年第5期45-45,共1页Digest of the World Core Medical Journals:Clinical Neurology

摘　　要：Management of acute ischemic stroke with IV unfractionated heparin is subject to debate. The authors evaluated patient-related and institutional factors in fluencing its use in 42 hospitals. Cardioembolic stroke type, carotid stenosis, atrial fibrillation, and treatment in stroke units or intensive care units signi ficantly increased the probability of use. However, there are large unexplained variations in IV heparin use among hospitals.Management of acute ischemic stroke with IV unfractionated heparin is subject to debate. The authors evaluated patient-related and institutional factors in fluencing its use in 42 hospitals. Cardioembolic stroke type, carotid stenosis, atrial fibrillation, and treatment in stroke units or intensive care units signi ficantly increased the probability of use. However, there are large unexplained variations in IV heparin use among hospitals.

关 键 词：缺血性卒中 肝素疗法 颈动脉狭窄 普通肝素 心房颤动 

分 类 号：R743[医药卫生—神经病学与精神病学]